CannaMD

NOVEMBER 20, 2020

a wealth of new research legitimizing marijuana’s role in patient care – here we are. Between 2000-2018, United States funding sources invested roughly 20 times more money into exposing marijuana’s harms than exploring its benefits. Cannabis vs. Opioids. For more details, see: Best Cannabis Disorder Treatment?

Therapy 79

Therapy Treatment DEA CBD 79

Cannabis Law Report

MARCH 3, 2022

An article covering Clinton’s on-stage conversation with CNN medical expert Sanjay Gupta at the Impact Forum in Orlando appeared in Cannabis & Tech Today last week, quoting the former president as saying there is some evidence that cannabidiol can help “combat pain.”. — Cannabis & Tech Today (@cannatechtoday) February 24, 2022.

Media 52

Media CBD Events THC 52

PrestoDoctor

JULY 16, 2019

Cannabis is just one case that represents the uphill battle it takes to overcome misinformation, fear, and even the hatred of groups of people, to gain sensible legislation. The gains created so far are largely credited to the work of cannabis reform groups. Prominent Cannabis Reform Groups in America and Beyond.

Policy 40

Policy DEA Access Media 40

PrestoDoctor

JULY 16, 2019

Cannabis is just one case that represents the uphill battle it takes to overcome misinformation, fear, and even the hatred of groups of people, to gain sensible legislation. The gains created so far are largely credited to the work of cannabis reform groups. Prominent Cannabis Reform Groups in America and Beyond.

Policy 40

Policy DEA Access Media 40

Cannabis Law Report

SEPTEMBER 12, 2021

Nevada voters approved medical marijuana for people by ballot initiative in 2000. Cannabis became legal for recreational use in the state on Jan. But do medical cannabinoids actually help animal patients? That said, the use, sale, and possession of cannabis over 0.3% 1, 2017, following a 2016 ballot measure.

Patients 105

Patients Pets Seed-To-Sale Cannabinoids 105

CannaMD

NOVEMBER 15, 2020

In the United States, most cannabis research to date has focused on the potential harms of the plant, instead of its benefits. funders use their money for cannabis research. His findings are sure to alarm medical cannabis professionals and patients alike. WHY ISN’T MORE RESEARCH DONE ON CANNABIS THERAPEUTICS?

DEA 105

DEA Clinical Trials Cannabinoids Treatment 105

Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. submitted his first DEA application to manufacture marijuana for use in medical research. On May 3, 2021, our study of MDMA-assisted therapy for PTSD achieved successful results for patients with severe, chronic PTSD. Rick Doblin, Ph.D., and Michael Mithoefer, M.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52